Cardinal Health, Inc. $CAH Shares Acquired by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 223.5% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 226,820 shares of the company’s stock after purchasing an additional 156,704 shares during the period. Cardinal Health accounts for approximately 2.3% of Fulcrum Asset Management LLP’s investment portfolio, making the stock its 3rd biggest position. Fulcrum Asset Management LLP owned approximately 0.10% of Cardinal Health worth $50,787,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CAH. BlackRock Inc. acquired a new stake in shares of Cardinal Health in the second quarter valued at about $6,293,115,000. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 247.5% in the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after acquiring an additional 10,584,119 shares during the period. Bank of America Corp DE bought a new stake in Cardinal Health in the second quarter valued at approximately $689,066,000. Legal & General Group Plc bought a new stake in Cardinal Health in the second quarter valued at approximately $438,870,000. Finally, Bank of New York Mellon Corp bought a new stake in Cardinal Health in the second quarter valued at approximately $308,640,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Fiscal Q1 adjusted EPS was $3.26, ahead of analyst expectations, while revenue rose 5% year over year to $67.5 billion and also topped estimates. The company raised its FY2027 adjusted EPS guidance to $12.80–$13.00, above the FactSet estimate of $12.57. Cardinal Health reports first-quarter results and raises outlook
• Positive Sentiment: Management cited specialty growth, strong demand for generics and customer renewals as supports for the raised outlook. Cardinal Health also completed a $500 million share repurchase program during the quarter. Q1 earnings call highlights
• Positive Sentiment: Royal Bank of Canada raised its price target to $295 from $276 and reiterated an “outperform” rating, signaling continued analyst optimism. Royal Bank of Canada recommendations
• Negative Sentiment: Medical distribution faced pressure, including modest commodity and petroleum-related headwinds. The company’s results and raised forecast indicate these pressures were outweighed by strength in pharmaceuticals and specialty. Cardinal Health sees healthy demand despite commodity pressure

Insider Buying and Selling

In other news, insider Michelle Greene sold 11,650 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total value of $2,746,138.00. Following the completion of the sale, the insider owned 10,330 shares in the company, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jason Hollar sold 44,529 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total transaction of $10,516,859.22. Following the transaction, the chief executive officer owned 190,603 shares in the company, valued at $45,016,616.54. The trade was a 18.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 210,271 shares of company stock worth $49,626,657 over the last ninety days. 0.12% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CAH has been the subject of several analyst reports. Citigroup raised their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 25th. Weiss Ratings raised shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research note on Thursday, October 8th. Morgan Stanley upped their price objective on shares of Cardinal Health from $265.00 to $286.00 and gave the company an “overweight” rating in a research note on Friday, October 30th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Cardinal Health from $215.00 to $260.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $272.50.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $270.99 on Monday. Cardinal Health, Inc. has a one year low of $180.45 and a one year high of $286.29. The stock’s 50-day moving average is $240.45 and its 200 day moving average is $223.55. The firm has a market cap of $62.75 billion, a price-to-earnings ratio of 35.06, a PEG ratio of 1.59 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, topping analysts’ consensus estimates of $2.94 by $0.32. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The business had revenue of $67.51 billion during the quarter, compared to the consensus estimate of $66.67 billion. During the same period in the previous year, the company posted $2.55 earnings per share. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, sell-side analysts expect that Cardinal Health, Inc. will post 12.86 EPS for the current fiscal year.

About Cardinal Health

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.

The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations.

Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.